PUBLISHER: The Business Research Company | PRODUCT CODE: 1597012
PUBLISHER: The Business Research Company | PRODUCT CODE: 1597012
Cas Nuclease Global Market Report 2024
Cas nuclease is an enzyme derived from CRISPR systems, capable of being programmed to target and cleave specific DNA sequences, thus enabling precise genetic modifications. It plays a crucial role in genome editing for correcting genetic mutations, creating genetically modified organisms, and developing targeted therapies for various diseases.
The primary types of Cas nucleases include Cas9, Cas12, Cas13, and others. Cas9 is a CRISPR-associated endonuclease that introduces double-strand breaks in DNA at specified locations, guided by a complementary RNA sequence, to facilitate accurate gene editing and manipulation. These nucleases can be delivered through various methods, including viral vectors, lipid nanoparticles, electroporation, microinjection, and transposons. Distribution channels for Cas nucleases encompass direct sales and distributors. Their applications range from gene editing and cell line construction to the development of animal models, bioagriculture, gene therapy, and more. Key end users of Cas nucleases include academic and government research institutions, biotechnology and pharmaceutical companies, contract research organizations (CROs), and agricultural biotechnology firms, among others.
The Cas nuclease market research report is one of a series of new reports from The Business Research Company that provides Cas nuclease market statistics, including Cas nuclease industry global market size, regional shares, competitors with a Cas nuclease market share, detailed Cas nuclease market segments, market trends and opportunities, and any further data you may need to thrive in the Cas nuclease industry. This Cas nuclease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The Cas nuclease market size has grown rapidly in recent years. It will grow from $2.75 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 18.9%. The growth during the historic period can be attributed to the rise of genome editing, increased funding for biotechnology research, heightened demand for personalized medicine, government support for genetic research, and the growing prevalence of genetic disorders.
The Cas nuclease market size is expected to see rapid growth in the next few years. It will grow to $6.56 billion in 2028 at a compound annual growth rate (CAGR) of 19.0%. The projected growth during the forecast period can be attributed to increasing investment in gene editing startups, rising demand for therapeutic genome editing, regulatory approvals for gene therapies, the development of Cas-based diagnostics, and growing interest in epigenome editing. Key trends expected in this period include the adoption of CRISPR for treating rare diseases, growth in agricultural gene editing, heightened interest in synthetic RNA-guided nucleases, advancements in CRISPR-based drug discovery, and a rise in ethical debates surrounding genome editing.
The increasing investment in biotechnology is projected to drive the growth of the Cas nuclease market in the coming years. This surge in investment is propelled by significant breakthroughs in scientific research, a rising demand for advanced medical treatments, the expanding applications of biotechnology across various industries, and the substantial economic potential associated with innovative technologies. Investment in biotechnology, particularly in Cas nucleases, accelerates advancements in gene-editing technologies applicable to medical, agricultural, and research fields. For example, in August 2024, data released by the UK Bioindustry Association (BIA), a trade association for the innovative life sciences and biotech sectors, indicated that the UK's life sciences and biotech sector raised $2.61 billion in the first half of 2024, surpassing the total of $2.38 billion raised throughout 2023. Consequently, the growing investment in biotechnology is driving the Cas nuclease market forward.
Key companies within the Cas nuclease market are concentrating on developing advanced technological solutions, such as CRISPR-based gene editing therapy, to maintain their competitive edge. CRISPR-based gene editing therapy employs the CRISPR-Cas9 system to precisely modify DNA sequences in living organisms, enabling the treatment of genetic disorders by correcting mutations at the molecular level. For instance, in November 2023, Vertex Pharmaceuticals Incorporated, a U.S.-based biotechnology firm, in collaboration with CRISPR Therapeutics, a Switzerland-based gene editing company, announced the authorization of CASGEVY (exagamglogene autotemcel) by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). This approval represents a significant milestone, as it is the first-ever gene therapy utilizing CRISPR/Cas9 technology approved for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in patients aged 12 and older.
In February 2024, Ginkgo Bioworks, a U.S.-based biotechnology company, acquired Proof Diagnostics Inc. for an undisclosed sum. This acquisition aims to bolster Ginkgo's gene editing capabilities by integrating Proof's innovative Omega ribonucleic acid (RNA) programmable nuclease libraries, providing a new, versatile tool for advancing genomic medicines and therapeutics. Proof Diagnostics Inc. is a U.S.-based life sciences company specializing in a cutting-edge, CRISPR-based platform that includes Omega nuclease and CRISPR Cas technologies.
Major companies operating in the cas nuclease market are Thermo Fisher Scientific Inc., AstraZeneca PLC, Merck KGaA, Vertex Pharmaceuticals, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Promega Corporation, GenScript Biotech Corporation, CRISPR Therapeutics AG, Integrated DNA Technologies Inc., Takara Bio Inc., New England Biolabs Inc., Horizon Discovery Group plc, OriGene Technologies Inc., Applied Biological Materials Inc. (ABM), Synthego Corporation, Novoprotein Scientific Inc., genOway, Precision BioSciences, Editas Medicine, Creative Biolabs, Cellectis, Caribou Biosciences, Addgene
North America was the largest region in the Cas nuclease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cas nuclease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cas nuclease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The Cas nuclease market consists of sales of CRISPR-Cas9 kits, Cas12a systems, Cas nuclease proteins, and gene-editing solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cas Nuclease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cas nuclease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cas nuclease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cas nuclease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Cas9; Cas12; Cas13; Other Cas Nucleases
- 2) By Delivery Method: Viral Vectors; Lipid Nanoparticles; Electroporation; Microinjection; Transposons
- 3) By Distribution Channel: Direct Sales; Distributor
- 4) By Application: Gene Editing Cell Line Construction; Animal Models; Bioagriculture; Gene Therapy; Other Applications
- 5) By End-User: Academic And Government Research Institutions; Biotechnology And Pharmaceutical Companies; Contract Research Organizations (CROS); Agricultural Biotechnology Companies; Other End-Users
- Companies Mentioned: Thermo Fisher Scientific Inc.; AstraZeneca PLC; Merck KGaA; Vertex Pharmaceuticals; Agilent Technologies Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cas Nuclease Market Characteristics
3. Cas Nuclease Market Trends And Strategies
4. Cas Nuclease Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Cas Nuclease Market Size and Growth
- 5.1. Global Cas Nuclease Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Cas Nuclease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Cas Nuclease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Cas Nuclease Market Segmentation
- 6.1. Global Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Cas9
- Cas12
- Cas13
- Other Cas Nucleases
- 6.2. Global Cas Nuclease Market, Segmentation By Delivery Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Viral Vectors
- Lipid Nanoparticles
- Electroporation
- Microinjection
- Transposons
- 6.3. Global Cas Nuclease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Direct Sales
- Distributor
- 6.4. Global Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Gene Editing Cell Line Construction
- Animal Models
- Bioagriculture
- Gene Therapy
- Other Applications
- 6.5. Global Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Academic And Government Research Institutions
- Biotechnology And Pharmaceutical Companies
- Contract Research Organizations (CROS)
- Agricultural Biotechnology Companies
- Other End-Users
7. Cas Nuclease Market Regional And Country Analysis
- 7.1. Global Cas Nuclease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Cas Nuclease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Cas Nuclease Market
- 8.1. Asia-Pacific Cas Nuclease Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Cas Nuclease Market
- 9.1. China Cas Nuclease Market Overview
- 9.2. China Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Cas Nuclease Market
- 10.1. India Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Cas Nuclease Market
- 11.1. Japan Cas Nuclease Market Overview
- 11.2. Japan Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Cas Nuclease Market
- 12.1. Australia Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Cas Nuclease Market
- 13.1. Indonesia Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Cas Nuclease Market
- 14.1. South Korea Cas Nuclease Market Overview
- 14.2. South Korea Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Cas Nuclease Market
- 15.1. Western Europe Cas Nuclease Market Overview
- 15.2. Western Europe Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Cas Nuclease Market
- 16.1. UK Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Cas Nuclease Market
- 17.1. Germany Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Cas Nuclease Market
- 18.1. France Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Cas Nuclease Market
- 19.1. Italy Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Cas Nuclease Market
- 20.1. Spain Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Cas Nuclease Market
- 21.1. Eastern Europe Cas Nuclease Market Overview
- 21.2. Eastern Europe Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Cas Nuclease Market
- 22.1. Russia Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Cas Nuclease Market
- 23.1. North America Cas Nuclease Market Overview
- 23.2. North America Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Cas Nuclease Market
- 24.1. USA Cas Nuclease Market Overview
- 24.2. USA Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Cas Nuclease Market
- 25.1. Canada Cas Nuclease Market Overview
- 25.2. Canada Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Cas Nuclease Market
- 26.1. South America Cas Nuclease Market Overview
- 26.2. South America Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Cas Nuclease Market
- 27.1. Brazil Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Cas Nuclease Market
- 28.1. Middle East Cas Nuclease Market Overview
- 28.2. Middle East Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Cas Nuclease Market
- 29.1. Africa Cas Nuclease Market Overview
- 29.2. Africa Cas Nuclease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Cas Nuclease Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Cas Nuclease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Cas Nuclease Market Competitive Landscape And Company Profiles
- 30.1. Cas Nuclease Market Competitive Landscape
- 30.2. Cas Nuclease Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. AstraZeneca PLC
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Merck KGaA
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Vertex Pharmaceuticals
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Agilent Technologies Inc.
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Thermo Fisher Scientific Inc.
31. Cas Nuclease Market Other Major And Innovative Companies
- 31.1. Bio-Rad Laboratories Inc.
- 31.2. Promega Corporation
- 31.3. GenScript Biotech Corporation
- 31.4. CRISPR Therapeutics AG
- 31.5. Integrated DNA Technologies Inc.
- 31.6. Takara Bio Inc.
- 31.7. New England Biolabs Inc.
- 31.8. Horizon Discovery Group plc
- 31.9. OriGene Technologies Inc.
- 31.10. Applied Biological Materials Inc. (abm)
- 31.11. Synthego Corporation
- 31.12. Novoprotein Scientific Inc.
- 31.13. genOway
- 31.14. Precision BioSciences
- 31.15. Editas Medicine
32. Global Cas Nuclease Market Competitive Benchmarking
33. Global Cas Nuclease Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cas Nuclease Market
35. Cas Nuclease Market Future Outlook and Potential Analysis
- 35.1 Cas Nuclease Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Cas Nuclease Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Cas Nuclease Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
